Hyperlipidemia, familial combined, LPL related: genes and variants

Explore variant evidence for Hyperlipidemia, familial combined, LPL related across 1 analyzed protein (LPL). Linked ClinVar records include 18 pathogenic or likely pathogenic variants, 11 variants of uncertain significance and 10 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-04. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Hyperlipidemia, familial combined, LPL related

ClinVar pathogenic and likely pathogenic variants linked to Hyperlipidemia, familial combined, LPL related

VariantPositionProtein partClinical label
LPL H268Y268Pathogenic / likely pathogenic (★★)
LPL W113R113Pathogenic / likely pathogenic (★★)
LPL R270C270Pathogenic / likely pathogenic (★★)
LPL D183N183Pathogenic / likely pathogenic (★★)
LPL P234L234Pathogenic / likely pathogenic (★★)
LPL A98T98Pathogenic / likely pathogenic (★★)
LPL G215E215Pathogenic / likely pathogenic (★★)
LPL I252T252Essential for determining substrate specificityPathogenic / likely pathogenic (★★)
LPL L279V279Pathogenic / likely pathogenic (★★)
LPL M328I328Pathogenic / likely pathogenic (★★)
LPL M1I1Pathogenic / likely pathogenic (★★)
LPL D277N277Pathogenic / likely pathogenic (★★)
LPL C302R302Pathogenic / likely pathogenic (★)
LPL C310Y310Pathogenic / likely pathogenic (★)
LPL G436R436PLATPathogenic / likely pathogenic (★)
LPL D231N231Pathogenic / likely pathogenic (★)
LPL A361T361PLATPathogenic / likely pathogenic (★)
LPL R197H197Pathogenic / likely pathogenic

Uncertain variants prioritized for review in Hyperlipidemia, familial combined, LPL related

VariantPositionProtein partClinical labelEvidence
LPL H268Q268Uncertain (★)+7: 2 other pathogenic changes within 3 positions; H268Y at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.892

Same protein, different disease

Diseases related to Hyperlipidemia, familial combined, LPL related

Frequently asked questions

Which genes have records linked to Hyperlipidemia, familial combined, LPL related?

This view contains 1 analyzed proteins: LPL. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 18 pathogenic or likely pathogenic variants, 11 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 40 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center